Characterisation of the cytokine response in the Acute Coronary Syndrome and its modulation with angiotensin-converting enzyme inhibition (Protocol B)

ISRCTN ISRCTN51684951
DOI https://doi.org/10.1186/ISRCTN51684951
Secondary identifying numbers N0436121377
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
16/08/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr SY Ooi
Scientific

Institute for Cardiovascular Research
G Floor, Jubilee Building
Leeds General Infirmary
Great George Street
Leeds
LS1 3EX
United Kingdom

Phone +44 (0)113 392 5404

Study information

Study designRandomised active controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Scientific title
Study objectivesTo define the effects that angiotensin-converting enzyme inhibitors have on circulating levels of the pro-inflammatory cytokines; tumour necrosis factor (TNF)-alpha and interleukin-6 (IL-6), and the anti-inflammatory cytokine; IL-10.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedAcute coronary syndrome
InterventionRandomised controlled trial. Random allocation to:
1. Standard management
2. Standard management + angiotensin-converting enzyme inhibitor
Intervention typeOther
Primary outcome measureCytokine levels measured in the blood peripheral venous blood
Secondary outcome measuresNot provided at time of registration
Overall study start date31/10/2002
Completion date31/10/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsNot provided at time of registration
Key inclusion criteriaThe patient population will be drawn from all patients admitted to the cardiac unit based at the Leeds General Infirmary or St James's University Hospital with chest pain within the preceding 24 h. Patients must have a history and electrocardiogram (ECG) changes consistent with a diagnosis of the Acute Coronary Syndrome.
Key exclusion criteriaPatients with ST elevation myocardial infarction
Date of first enrolment31/10/2002
Date of final enrolment31/10/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Institute for Cardiovascular Research
Leeds
LS1 3EX
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Hospital/treatment centre

Leeds Teaching Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan